GD3 GENESIS DRUG DISCOVERY & DEVELOPMENT
Live / Registered — Registered (as of 22 Jun 2021)
What this means for you
Registered since 22 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87660522
- Registration number
- 6396881
- Mark type
- Design + words
- Filed
- 26 Oct 2017
- Published for opposition
- 17 Mar 2020
- Registered
- 22 Jun 2021
- Attorney of record
- Christina E. Brule
Goods and services
- Class 042 — Scientific and technological services: Scientific study and research in the fields of medicine, the prevention and treatment of illness, drug screening, mode of action of medicines in animal models, and pharmacokinetic evaluation and preclinical evaluation of lead compounds in drug discovery
Owner
- Genesis Drug Discovery & Development, LLC, Hamilton, NJ, US
- Genesis Drug Discovery & Development, LLC, Hamilton, NJ, US
- Genesis Drug Discovery & Development, LLC, Hamilton, NJ, US
Prosecution history
- 15 Sept 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 15 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 18 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Apr 2021 — ASSIGNED TO EXAMINER
- 28 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Nov 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Nov 2020 — NON-FINAL ACTION E-MAILED
- 02 Nov 2020 — SU - NON-FINAL ACTION - WRITTEN
- 31 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE